198 related articles for article (PubMed ID: 24871302)
1. An integrated mRNA and microRNA expression signature for glioblastoma multiforme prognosis.
Xiong J; Bing Z; Su Y; Deng D; Peng X
PLoS One; 2014; 9(5):e98419. PubMed ID: 24871302
[TBL] [Abstract][Full Text] [Related]
2. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma.
Zhang J; Bing Z; Yan P; Tian J; Shi X; Wang Y; Yang K
J Gene Med; 2019 Aug; 21(8):e3105. PubMed ID: 31215090
[TBL] [Abstract][Full Text] [Related]
3. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
Xiong J; Xiong K; Bing Z
Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
[TBL] [Abstract][Full Text] [Related]
4. Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma.
Li R; Gao K; Luo H; Wang X; Shi Y; Dong Q; Luan W; You Y
J Exp Clin Cancer Res; 2014 Jan; 33(1):9. PubMed ID: 24438238
[TBL] [Abstract][Full Text] [Related]
5. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
[TBL] [Abstract][Full Text] [Related]
6. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
7. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
Huang QR; Li JW; Pan XB
Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
[TBL] [Abstract][Full Text] [Related]
8. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
[TBL] [Abstract][Full Text] [Related]
9. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
10. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
Prasad B; Tian Y; Li X
Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
[TBL] [Abstract][Full Text] [Related]
11. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
Wang H; Liu D; Yang J
Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292
[TBL] [Abstract][Full Text] [Related]
12. Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.
Volinia S; Croce CM
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7413-7. PubMed ID: 23589849
[TBL] [Abstract][Full Text] [Related]
13. Identify signature regulatory network for glioblastoma prognosis by integrative mRNA and miRNA co-expression analysis.
Bing ZT; Yang GH; Xiong J; Guo L; Yang L
IET Syst Biol; 2016 Dec; 10(6):244-251. PubMed ID: 27879479
[TBL] [Abstract][Full Text] [Related]
14. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA signatures predict prognosis of patients with glioblastoma multiforme through the Cancer Genome Atlas.
Yuan Y; Zhang H; Liu X; Lu Z; Li G; Lu M; Tao X
Oncotarget; 2017 Aug; 8(35):58386-58393. PubMed ID: 28938564
[TBL] [Abstract][Full Text] [Related]
16. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.
Henriksen M; Johnsen KB; Olesen P; Pilgaard L; Duroux M
Neuromolecular Med; 2014 Sep; 16(3):565-77. PubMed ID: 24817689
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of micro-RNA, gene expression, and survival of glioblastoma multiforme.
Huang YT; Hsu T; Kelsey KT; Lin CL
Genet Epidemiol; 2015 Feb; 39(2):134-43. PubMed ID: 25537983
[TBL] [Abstract][Full Text] [Related]
20. A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma.
Zuo S; Zhang X; Wang L
Sci Rep; 2019 Feb; 9(1):2615. PubMed ID: 30796273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
